Skip to content
Menu

United Therapeutics Corporation UTHR

Full chart Compare
Set alert

Price alert · UTHR

All alert types
577.34 USD -6.76 (-1.16%)

Regular-session close

577.34 0.00 0.00%

After hours · Nov 18, 6:19 PM ET

569.34 Day range 588.43
455.63 52-week range 614.23
YTD
+18.49%
1 year
+21.14%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$196.70MGross Profit$2.80BCost of Revenue$384.40MGross Profit & Other Income$3.00BNet Income$1.33BSelling, General & Admin$731.10MResearch & Development$550.00MIncome Tax$379.20MRevenue$3.18BTyvaso$1.88BRemodulin$526.80MOrenitram$496.90MUnituxin$226.80MAdcirca$30.00MProduct and Service, Other$24.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

UTHR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.18B2.88B2.33B1.94B1.69B
2.80B2.57B2.07B1.78B1.56B
1.49B1.38B1.18B979.70M555.90M
1.33B1.20B984.80M727.30M475.80M
27.8624.6419.8115.0010.06
UTHR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.56B1.70B1.21B961.20M894.80M
7.88B7.36B7.17B6.04B5.17B
783.80M920.00M1.18B1.25B1.21B
7.10B6.44B5.98B4.80B3.96B
UTHR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.56B1.33B978.00M802.50M598.20M
-551.30M417.20M-719.60M-811.50M-486.90M
-1.15B-1.25B-11.90M75.40M44.80M
-520.50M-246.50M-230.40M-138.80M-120.80M
-140.10M489.50M246.50M66.40M156.10M